Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Smart & Biggar’ returned 2,497 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Cannabis – From Mystery To Medical IP

    Cannabis still maintains much of its mystery, thousands of years after it was first used by humans. There is great uncertainty among modern medical practitioners ...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Draft Revised PMPRB Guidelines Released For Comment By December 5, 2022

    On October 6, 2022, the Patented Medicine Prices Review Board (PMPRB) released its revised draft Guidelines to give effect to the July 1, 2022 amendments to the Patented Medicines Regulations.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada's Proposed Regulatory Amendments To Address Health Product Shortages

    On June 25, 2024, Health Canada published a notice of intent and Building resilience: Health Canada's plan to address health product shortages, 2024 to 2028...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Launches New Clinical Trial Search Portal And Publishes Updated Guidance

    Health Canada has launched a new Clinical Trial Search Portal and released updated guidance on clinical trial registration and public disclosure of results. The portal provides searchable information on Health Canada-authorized clinical trials for pharmaceutical, biologic and radiopharmaceutical drugs, while the guidance outlines expectations for sponsors regarding trial registration and summary result reporting.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Publishes Final Guidance Documents On Quality Requirements For Regulatory Filings

    Health Canada publishes final guidance documents on quality requirements for regulatory filings
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Le CEPMB publie son Rapport annuel sur les dépenses des régimes publics d'assurance médicaments (2022-2023)

    Le 21 octobre 2025, le Conseil d'examen du prix des médicaments brevetés (CEPMB) a annoncé la publication de CompasRX (10e édition)...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    PMPRB Proposes To Modify Guidelines Definition Of "gap Medicine" To Include Medicines Sold By July 1, 2021

    As previously reported, regulations further amending the coming into force date of the Regulations Amending the Patented Medicines Regulations
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Updated And New Draft Health Canada Guidance Documents Related To Medical Devices

    On August 30, 2023, Health Canada opened consultation on its draft pre-market guidance for machine learning-enabled medical devices (MLMD), i.e., medical devices...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    After The U.S. Supreme Court Decision In Alice v CLS Bank: Is It Time For A Combined North American Approach?

    The decision of the U.S. Supreme Court in Alice v CLS Bank (573 U.S. ____ (2014)), and its impact on the patent eligibility of computer-implemented inventions, has been the subject of considerable commentary in the patent press.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Canada’s New Trademark Regime – Impact On Renewals, Allowance And Classification

    The Canadian government has proposed sweeping changes to the Trade-marks Act that will impact current and new applications and registrations.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Canadian Domain Name Dispute Resolution Policy Now In Force

    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Federal Court Of Appeal Upholds Federal Court Decision Finding Shire's VYVANSE Patent Valid

    The FCA recently dismissed an appeal by Apotex from a decision of the Federal Court holding that the claims of Canadian Patent No. 2,527,646 were valid, and prohibiting the Minister of Health from issuing a Notice of Compliance to Apotex ...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    How Do You Know When You Have Something To Protect?

    While all companies invest resources in developing and improving their products and services, few actively consider using the patent system to leverage their investment.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Retailers’ Challenge Of The OQLF’s Interpretation Of The Charter Of The French Language

    On October 9, 2012, six retailers, BEST BUY, COSTCO, GAP, OLD NAVY, GUESS? and WAL-MART, filed a motion in the Superior Court of Québec seeking a declaratory judgement against the "Office québécoise de la langue française".
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    You Can't Patent Software, Right?! …Or Can You?

    This is a common misconception.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Federal Privacy Commissioner Issues Results Of Online Privacy Policy Sweep

    In August, Canada’s Privacy Commissioner released results of an international sweep of online privacy policies for more than 2,000 websites and apps conducted with other global data protection authorities.
    CanadaPrivacy
    Smart & Biggar
    Smart & Biggar
  • Article

    AI & Privacy: PrActIcal AdvIce For OrgAnIzAtIons

    As people offer increasing amounts of personal information, they are becoming more aware of the importance of this information, and its potential uses and misuses.
    CanadaPrivacy
    Smart & Biggar
    Smart & Biggar
  • Article

    Contrasts And Distinctions: Canadian Patent Law Developments In 2018

    2018 served up a smorgasbord of disparate patent law developments in Canada. Most notably, ratification of a new trade agreement negotiated amongst Canada ...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Announces Further Steps On The "Action Plan On Medical Devices"

    The SAC-HPW will provide advice on issues regarding women's health and regulation of medical devices and drugs.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Grey Marketing – Still Not Black and White in Canada

    Grey marketing, sometimes referred to as "parallel importation", is the diversion of goods, originally intended for sale only in certain countries, to other countries where they were not intended to be sold.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Showing 801–820 of 2497 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics